Glucagon-like peptide-2 and its therapeutic use
CA 2218225 C · Owner: Drucker, Daniel J. · Inventors: Drucker, Daniel J.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Glucagon-like peptide-2, a product of glucagon gene expression and analogs of glucagon-like peptide-2 have been identified as gastrointestinal tissue growth factors. Their effects on the growth of small bowel and pancreatic islets are described. Their formulation as a pharmaceutical and their therapeutic use in treating disorders of the bowel are described.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 12, 1996 and granted September 23, 2014. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended April 12, 2016.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 12, 2018.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.